المؤلفون: Ramon Arntz, Serena Martelli, R. Gutzmer, Nicholas Squittieri, Dirk Schadendorf, Caroline Robert, Carmen Loquai, Reinhard Dummer

المساهمون: University of Zurich, Gutzmer, Ralf

المصدر: BMC Cancer, Vol 21, Iss 1, Pp 1-9 (2021)
BMC Cancer

مصطلحات موضوعية: Adult, Cancer Research, Skin Neoplasms, Pyridines, medicine.medical_treatment, Medizin, Tumor outcome, Vismodegib, 610 Medicine & health, mRECIST, Drug Administration Schedule, Hedgehog pathway inhibitor, Sonidegib, chemistry.chemical_compound, Double-Blind Method, 1311 Genetics, Confidence Intervals, Genetics, Humans, Medicine, Anilides, Basal cell carcinoma, 1306 Cancer Research, Response Evaluation Criteria in Solid Tumors, RC254-282, medicine.diagnostic_test, business.industry, Research, Biphenyl Compounds, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, 10177 Dermatology Clinic, Magnetic resonance imaging, medicine.disease, Confidence interval, Radiation therapy, Treatment Outcome, chemistry, Oncology, Carcinoma, Basal Cell, Disease Progression, 2730 Oncology, business, Nuclear medicine, Progressive disease, medicine.drug

وصف الملف: 924_Gutzmer_R._et_al._Assessment_of_various_efficacy_outcomes_using_ERIVANCE-like_criteria_in_patients_with_locally_advanced_basal_cell_carcinoma_receiving_sonidegib_BMC_Cancer_2021.pdf - application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db8d273e34be76c08b02bf466b6db805Test
https://doi.org/10.5167/uzh-210585Test

المؤلفون: Christoph Hoeller, Katarina Öhrling, Caroline Robert, Olivier Michielin, Axel Hauschild, Caroline Caramella, Mark R. Middleton

المصدر: British Journal of Cancer

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Metastatic melanoma, medicine.medical_treatment, Immune checkpoint inhibitors, Review Article, Unmet needs, Metastasis, 03 medical and health sciences, 0302 clinical medicine, Immune system, Internal medicine, medicine, Humans, Melanoma, Immune Checkpoint Inhibitors, 030304 developmental biology, Oncolytic Virotherapy, 0303 health sciences, business.industry, Treatment options, Granulocyte-Macrophage Colony-Stimulating Factor, Immunotherapy, medicine.disease, Oncolytic virus, 030220 oncology & carcinogenesis, Receptors, Pattern Recognition, Interleukin-2, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee068b0d49ba040e0d0087ddfe50259cTest
http://europepmc.org/articles/PMC7492252Test

المؤلفون: Paolo A. Ascierto, Dirk Schadendorf, Selma Ugurel, Alexander M.M. Eggermont, Reinhardt Dummer, Elisabeth Livingstone, Lisa Zimmer, Anne Zaremba, Georgina V. Long, Caroline Robert

المساهمون: University of Zurich, Schadendorf, Dirk

مصطلحات موضوعية: Oncology, medicine.medical_specialty, Cancer Research, medicine.medical_treatment, Medizin, 610 Medicine & health, Pembrolizumab, Targeted therapy, chemistry.chemical_compound, Internal medicine, medicine, Humans, 1306 Cancer Research, Immune Checkpoint Inhibitors, Melanoma, Entinostat, business.industry, 10177 Dermatology Clinic, Immune checkpoint, Clinical trial, chemistry, 2730 Oncology, Immunotherapy, Nivolumab, business, Lenvatinib, Adjuvant

وصف الملف: 906_Zaremba_A._et_al._The_concepts_of_rechallange_and_retreatment_with_immune_checkpoints_blockade_in_melanoma_patients_EJC_2021.pdf - application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0af59f477caa0569ca2410181854e889Test
https://www.zora.uzh.ch/id/eprint/206131Test/

المؤلفون: Caroline Robert

المصدر: Nature Communications
Nature Communications, Vol 11, Iss 1, Pp 1-3 (2020)

مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_specialty, Science, medicine.medical_treatment, Immune checkpoint inhibitors, Programmed Cell Death 1 Receptor, Cancer therapy, General Physics and Astronomy, Cancer immunotherapy, 02 engineering and technology, Antibodies, Monoclonal, Humanized, General Biochemistry, Genetics and Molecular Biology, B7-H1 Antigen, 03 medical and health sciences, Antineoplastic Agents, Immunological, Internal medicine, Neoplasms, medicine, Humans, CTLA-4 Antigen, Clinical efficacy, lcsh:Science, Multidisciplinary, biology, business.industry, Comment, Cancer, Antibodies, Monoclonal, General Chemistry, Immunotherapy, 021001 nanoscience & nanotechnology, medicine.disease, Ipilimumab, 030104 developmental biology, Nivolumab, Toxicity, Monoclonal, biology.protein, Tumour immunology, lcsh:Q, Antibody, 0210 nano-technology, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dbaf2f8ae9ec128dbeaf95d89fd1c645Test
http://europepmc.org/articles/PMC7393098Test

المؤلفون: Paolo A. Ascierto, Dirk Schadendorf, Reinhard Dummer, Caroline Robert, Paul Nathan

مصطلحات موضوعية: Oncology, Proto-Oncogene Proteins B-raf, Cancer Research, medicine.medical_specialty, Skin Neoplasms, Metastatic melanoma, Immune checkpoint inhibitors, medicine.medical_treatment, Medizin, Context (language use), Targeted therapy, 03 medical and health sciences, 0302 clinical medicine, Immune system, Internal medicine, medicine, Tumor Microenvironment, Humans, 030212 general & internal medicine, Molecular Targeted Therapy, Immune Checkpoint Inhibitors, Melanoma, Tumor microenvironment, business.industry, medicine.disease, Clinical trial, 030220 oncology & carcinogenesis, Immunotherapy, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f1ca59ce0a443693aed8c8e11018ab9Test
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85092193946Test

المؤلفون: Caroline Robert, Jacob Schachter, Thierry Lesimple, C. Dutriaux, Dirk Schadendorf, Monique Tan, Axel Hauschild, Georgina V. Long, R. Dummer, Eduard Gasal, Mario Santinami, Kohinoor Dasgupta, James Larkin, Mario Mandalà, Andrew M. Haydon, John M. Kirkwood, Vanna Chiarion Sileni, Laurent Mortier, Victoria Atkinson, Marta Nyakas, Ruth Plummer

المساهمون: University of Zurich

مصطلحات موضوعية: Male, Oncology, Skin Neoplasms, medicine.medical_treatment, Medizin, Administration, Oral, 2700 General Medicine, 030204 cardiovascular system & hematology, law.invention, 0302 clinical medicine, Randomized controlled trial, law, Antineoplastic Combined Chemotherapy Protocols, Oximes, Medicine, 030212 general & internal medicine, Neoplasm Metastasis, Melanoma, Trametinib, Imidazoles, Follow up studies, 10177 Dermatology Clinic, General Medicine, Middle Aged, Female, Adjuvant, medicine.drug, Adult, Proto-Oncogene Proteins B-raf, medicine.medical_specialty, Pyridones, 610 Medicine & health, Pyrimidinones, Disease-Free Survival, 03 medical and health sciences, Adjuvants, Immunologic, Double-Blind Method, Internal medicine, Humans, Stage III melanoma, Protein Kinase Inhibitors, Survival analysis, Aged, Neoplasm Staging, business.industry, Dabrafenib, Survival Analysis, Clinical trial, Mutation, business, Follow-Up Studies

وصف الملف: 848_Dummer_R._et_al._Five-Year_Analysis_of_Adjuvant_Dabrafenib_plus_Trametinib_in_Stage_III_Melanoma_NEJM_2020.pdf - application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d710d2b0f671e5dafc838391b9965d4aTest
https://www.zora.uzh.ch/id/eprint/190018Test

المؤلفون: P. Siegel, C. M. C. Oude Ophuis, Piotr Rutkowski, A.C.J. van Akkooi, Alessandro Testori, B.L. van Leeuwen, Caroline Robert, Alexander M.M. Eggermont, Cees Verhoef, Dirk J. Grünhagen, W. E. M. Powell

المساهمون: Damage and Repair in Cancer Development and Cancer Treatment (DARE), Guided Treatment in Optimal Selected Cancer Patients (GUTS), Clinical Cognitive Neuropsychiatry Research Program (CCNP), Surgery

المصدر: British Journal of Surgery, 104(6), 726-733. Wiley
British Journal of Surgery, 104(6), 726-733. John Wiley & Sons Ltd.

مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Skin Neoplasms, PROGNOSIS, CUTANEOUS MELANOMA, medicine.medical_treatment, Sentinel lymph node, MULTICENTER, 030230 surgery, Disease-Free Survival, Time-to-Treatment, 03 medical and health sciences, 0302 clinical medicine, SDG 3 - Good Health and Well-being, Biopsy, medicine, Humans, RECURRENCE, Lymph node, Melanoma, DISSECTION, Retrospective Studies, medicine.diagnostic_test, business.industry, Proportional hazards model, Sentinel Lymph Node Biopsy, Retrospective cohort study, Sentinel node, Middle Aged, medicine.disease, Surgery, Tumor Burden, TIME, medicine.anatomical_structure, Treatment Outcome, 030220 oncology & carcinogenesis, Lymphatic Metastasis, SURVIVAL, Lymph Node Excision, UPDATE, Lymphadenectomy, Female, TRIAL, Radiology, Sentinel Lymph Node, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f643294a9b6bc79a077f7543eaf2a9a3Test
https://hdl.handle.net/11370/3f2d7a4f-68ba-46b4-8f56-89b5b904d933Test

المؤلفون: Paolo A. Ascierto, Amy P. Abernethy, Georgina V. Long, Fiona Taylor, Homa Dastani, Victoria Atkinson, Isabelle Gilloteau, Piotr Rutkowski, Caroline Robert, Kerry J. Savage, Ian M. Waxman, C. Coon, Jessica C. Hassel

المصدر: Annals of Oncology

مصطلحات موضوعية: Oncology, advanced melanoma, Adult, Male, medicine.medical_specialty, Adolescent, medicine.medical_treatment, Dacarbazine, Programmed Cell Death 1 Receptor, Checkmate, Kaplan-Meier Estimate, Disease-Free Survival, 03 medical and health sciences, 0302 clinical medicine, Quality of life, Internal medicine, Surveys and Questionnaires, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, In patient, programmed death-1 receptor, CTLA-4 Antigen, 030212 general & internal medicine, Melanoma, Advanced melanoma, Aged, Health related quality of life, nivolumab, Aged, 80 and over, Chemotherapy, business.industry, Antibodies, Monoclonal, Hematology, Original Articles, Middle Aged, humanities, Surgery, health-related quality of life, 030220 oncology & carcinogenesis, Quality of Life, Female, Nivolumab, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c7407a5a8ba2595d743659fa62f544fTest
http://europepmc.org/articles/PMC5035785Test

المؤلفون: Patricia Lepage, Clélia Coutzac, David Faleck, Franck Carbonnel, Lysiane Marthey, Michael Collins, Nathalie Chaput, Emilie Soularue, Jean-Frederic Colombel, Caroline Robert

المساهمون: Department of Gastroenterology, AP-HP Hôpital Bicêtre (Le Kremlin-Bicêtre), Faculté de Médecine, Université de Ngozi, MICrobiologie de l'ALImentation au Service de la Santé (MICALIS), Institut National de la Recherche Agronomique (INRA)-AgroParisTech, Université Paris Saclay (COmUE), Icahn School of Medicine at Mount Sinai, Partenaires INRAE, Centre National de la Recherche Scientifique (CNRS), Analyse moléculaire, modélisation et imagerie de la maladie cancéreuse (AMMICa), Centre National de la Recherche Scientifique (CNRS)-Université Paris-Sud - Paris 11 (UP11)-Institut Gustave Roussy (IGR)-Institut National de la Santé et de la Recherche Médicale (INSERM), Faculté de Pharmacie, Université Paris-Sud - Paris 11 (UP11), Institut Gustave Roussy (IGR), AbbVie, Takeda, Janssen

المصدر: Gut
Gut, BMJ Publishing Group, 2018, 67 (11), pp.2056-2067. ⟨10.1136/gutjnl-2018-316948⟩

مصطلحات موضوعية: 0301 basic medicine, medicine.medical_treatment, [SDV]Life Sciences [q-bio], chemical and pharmacologic phenomena, Gut flora, Inflammatory bowel disease, 03 medical and health sciences, 0302 clinical medicine, Antineoplastic Agents, Immunological, Risk Factors, medicine, Cytotoxic T cell, Humans, Adverse effect, Enterocolitis, biology, business.industry, Gastroenterology, Cancer, Endoscopy, Immunotherapy, Cell Cycle Checkpoints, biology.organism_classification, medicine.disease, 3. Good health, Blockade, Gastrointestinal Microbiome, 030104 developmental biology, 030220 oncology & carcinogenesis, Immunology, medicine.symptom, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5f22498230026f9a0e67238e5bf2b9dTest
https://hal.inrae.fr/hal-02626171Test

المؤلفون: Christian U. Blank, Adil Daud, Rene Gonzalez, Kim Margolin, Scot Ebbinghaus, Ziwen Wei, Dirk Schadendorf, Antoni Ribas, Anna C. Pavlick, Lee D. Cranmer, Caroline Robert, April K.S. Salama, Jacob Schachter, Omid Hamid, Reinhard Dummer, Nageatte Ibrahim, F. Stephen Hodi, Igor Puzanov, Tara C. Gangadhar, Paolo A. Ascierto

المساهمون: University of Zurich, Hamid, Omid

مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Cancer Research, Skin Neoplasms, Time Factors, medicine.medical_treatment, Medizin, Phases of clinical research, Pembrolizumab, Kaplan-Meier Estimate, 0302 clinical medicine, Antineoplastic Agents, Immunological, 1306 Cancer Research, Melanoma, Aged, 80 and over, education.field_of_study, Cross-Over Studies, Drug Substitution, Hazard ratio, 10177 Dermatology Clinic, Middle Aged, MAP Kinase Kinase Kinases, Treatment Outcome, 030220 oncology & carcinogenesis, Disease Progression, 2730 Oncology, Female, medicine.drug, Adult, Proto-Oncogene Proteins B-raf, medicine.medical_specialty, Adolescent, Population, Ipilimumab, 610 Medicine & health, Antibodies, Monoclonal, Humanized, Disease-Free Survival, 03 medical and health sciences, Young Adult, Internal medicine, medicine, Humans, education, Protein Kinase Inhibitors, Aged, Chemotherapy, business.industry, medicine.disease, Confidence interval, Surgery, 030104 developmental biology, Drug Resistance, Neoplasm, Mutation, business

وصف الملف: 721_Hamid_O._et_al._Final_analysis_of_randomised_trial_comparing_pembrolizumab_versus_Eur_J_Cancer_2017.pdf - application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab24a3779538f584d0432f320113cbb5Test
https://www.ncbi.nlm.nih.gov/pubmed/28961465Test